HNF1A and type 1 diabetes mellitus: Lastly, we extended our findings to diabetic patients and measured circulating miR-375 levels in human subjects with inactivating mutations in HNF1α (maturity-onset of the young, type 3 (MODY3)), T2D, T1D, and healthy subjects (no diagnosed metabolic disease (NDMD)).